My PhD thesis focuses on developing a novel and personalized therapeutic vaccine against ovarian cancer and melanoma using autologous B cells.
I obtained both my Bachelor's of Science in biotechnology and my Master's in medical biotechnologies at the University of Siena (Italy). I joined the laboratory of Pr Lana Kandalaft as a PhD student in April 2022.
My current research interests focus on: i) investigating the impact and mechanisms of HOCl in improving the immunogenicity of cancer antigens; ii) developing a novel platform and pipeline for a therapeutic cancer vaccine and iii) identifying immunomodulatory effects of key metabolites and their impact on the therapeutic efficacy of DC-based cancer vaccines.
I hold a Bachelor’s in Chemistry from the University of Padua and a Master’s in Chemistry of Biological Systems from the University of La Sapienza, Rome. I received a PhD in Cell Physiology and Pharmacology from the University of Leicester studying P. falciparum kinases as novel drug targets against malaria. I was also a postdoctoral researcher at EPFL, the Swiss Federal Institute of Technology in Lausanne, conducting a high-throughput screening aimed at identifying novel modulators of centriole duplication and cancer cell division.
My interest is in advanced science capable of improving our patients’ lives.
I did my apprenticeship as a laboratory technician at Novartis. Prior to joining the Department of oncology UNIL CHUV, I worked for five years on research into blood cancers at the Inselspital in Bern.
My PhD thesis focuses on the development of a novel B cell-based vaccine for metastatic solid cancers.
I hold a Bachelor’s in Medical Laboratory Sciences and a Master’s in Biological Sciences from the American University of Beirut. I started my PhD in the lab of Pr Lana Kandalaft in February 2022.
I am currently in charge of pre-clinical and clinical projects investigating the immunological signatures of interventional radiology treatments in cancer, with an aim of expanding the IR’s applicative horizons beyond local therapies.
I hold a PhD in Cancer Biology from the University of Zurich, and have a decade of experience in the fields of cellular immunology and hematology.
Ludwig adjunct scientist
Laboratory L. Kandalaft
Department of oncology UNIL CHUV
Ludwig Institute for Cancer Research Lausanne
Head of Center of experimental therapeutics, Lausanne University Hospital (CHUV)
Phone +41 21 314 78 23
Fax +41 21 314 10 33
AGORA Cancer Research Centre
Rue du Bugnon 25A